MENU
MENU
Our World
Corporate Overview
Our Management
Our Purpose
Our Manufacturing Capabilities
Quality
Partnerships
Key Milestones
Regulatory Filings & Approvals
Awards & Recognition
Environment & Safety
Our Brands
Distribution Network
Divisions
Products
Zenlabs
Analgesics & Anti-Inflammatory
Skin Preparations
Neurological Disorders
Eye, Ear and Nasal Drops
Anti-Diabetic
Anti-Depressant
Anti-Infective
Anti-Emetic
Steroid & Anabolic Steroid
Anti-Hypertensive Drugs
Anti Allergic, Anti Cold & Cough Syrup
Nutraceuticals
Antacid, Enzymes & Appetite Stimulant
Ayurvedic Preparation
GIT Disorders
Soap
Other Pharmaceutical Drugs
Coles Pharma
Analgesics & Anti-Inflammatory
Nutraceuticals
Skin Preparations
Neurological Disorders
Anti-Emetic
Anti-Infective
Ear, Eye and Nasal Drops
Anti-Diabetic Drugs
Anti-Depressant Drugs
Steroids & Anabolic Steroids
Anti-Hypertensive Drugs
Anti-Allergic, Anti-Cold & Cough Syrup
Antacid, Enzymes & Appetite Stimulant
GIT Disorders
Ayurvedic Preparation
Soap
Dusting Powder
Other Pharmaceutical Drugs
Mega Star
Analgesics & Anti-Inflammatory
Nutraceuticals
Skin Preparations
Neurological Disorders
Anti-Emetic
Anti-Infective
Steroids And Anabolic Steroids
Anti-Hypertensive Drugs
Anti-Allergic, Anti-Cold & Cough Syrup
Antacid, Enzymes & Appetite Stimulant
GIT Disorders
Soap
Dusting Powder
Ayurvedic Preparations
Other Pharmaceutical Drugs
Business
Online Enquiries
Blog
Stock Exchange Filings
24-25
Quarterly
Q1
Q2
Q1
Trading Window Closure
Corporate Governance Non-Applicability Certificate
Shareholding Pattern
Share Reconciliation Report
Investor Grievances
Compliance Certificate as per Reg. 74(5)
Q2
Trading Window Closure
23-24
Quarterly
Q1
Q2
Q3
Q4
Q1
Trading window notice
Corporate Governance Report as per Reg 27(2)
Compliance Certificate under Reg 74(5) of the SEBI DP Regulations 2018
Shareholding Pattern for the Quarter ended 30 June, 2023
Statement of Investor Complaint
Share Reconciliation Audit Report
Q2
Corporate Governance Report as per Reg 27(2)
Shareholding Pattern for the Quarter ended 30 September, 2023
Compliance Certificate under Reg 74(5) of the SEBI DP Regulations 2018
Statement of Investor Complaint
Share Reconciliation Audit Report
Window Closing Letter
Q3
Trading Window Closure Notice
Corporate Governance Exemption Certificate
Shareholding Pattern for Quarter ended 31st Dec, 2023
Share Reconciliation Report
Compliance Certificate under Reg. 74(5) of SEBI (DP)Regulations 2018
Statement of Investor Complaint
Q4
Trading Window Closure Notice
Corporate Governance Exemption Certificate
Shareholding Pattern for Quarter ended 31st March, 2024
Share Reconciliation Report
Compliance Certificate under Reg. 74(5) of SEBI (DP)Regulations 2018
Statement of Investor Complaint
Yearly
Compliance Certificate Reg. 7(3) SEBI LODR 2015
Compliance Certificate Reg. 40(9) SEBI LODR 2015
22-23
Quarterly
Q1
Q2
Q3
Q4
Q1
Corporate Governance Reg 27(2)
Reconciliation of sh capital audit report
Reg 74(5) of SEBI DP Reg
Shareholding Pattern Q1 FY 22-23
Trading window notice
Q2
Closure of Trading window-30.09.2022
ACK
Corporate Governance Reg 27(2)
Reg 74(5) of SEBI(DP) Reg. 2018
Ack-Inv Complaints
ZENLABS IG 30092022
Acknowledgement
SDD Compliance Certificate
Shareholding Pattern Q2 FY 22-23
Reconciliation of share capital audit report
Q3
ACK-SDD
Reconciliation of share capital audit report
Corporate Governance Reg 27(2)
Reg 74(5) of SEBI(DP) Reg. 2018
Shareholding Pattern Q3 22-23
Q4
Trading Window Closure
BSE INTIMATION CG Reg 27
Zenlabs IG
BSE Reg 76 SEBI (DP)
BSE INTIMATION Reg 74(5) SEBI(DP)
Shareholding Pattern Q4 FY-22-23
SDD COMPLIANCE
Q1
Q2
Q3
Q4
Q1
ACK-SDD
SCHEDULE OF CHARGES FOR iTRACK CNTRP
SDD Compliance Certificate final
Q2
ACK-SDD-18-11-2022
SDD COMPLIANCE CERTIFICATE
CERTIFICATE - SDD- 18-11-2022
Q3
ACK-SDD
SDD COMPLIANCE CERTIFICATE
CERTIFICATE - SDD- 19-01-2023
Q4
SDD
BSE Intimation_Reg 7(3) LODR
REG 40(10) LODR-31.03.2023
Yearly
BSE Intimation Reg 7(3) LODR
Regulation 30 SAST-31.03.2022
REG 40(10) LODR-31.03.2022
21-22
Quarterly
Q1
Q2
Q3
Q4
Q1
Corporate Governance Reg 27(2)
Reconciliation of sh capital audit report
Reg 74(5) of SEBI DP Reg
Shareholding Pattern-30.06.2021
Trading window Closure
Q2
Closure of Trading window-30.09.2021
Reconciliation of share capital audit report
Corporate Governance Reg 27(2)
74(5) SEBI(DP) Reg. 2018
Shareholding Pattern-30.09.2021
Q3
Trading Window close-31.12.2021
Reconciliation of sh capital audit report
Corporate Governance Reg 27(2)
74(5) SEBI(DP) Reg. 2018
Shareholding Pattern-31.12.2021
Q4
Trading Window Closure-31.03.22
Reconciliation of sh capital audit report
Corporate Governance Reg 27(2)
74(5) SEBI(DP) Reg. 2018
Shareholding Pattern - 31.03.2022
Yearly
BSE Intimation Reg 7(3) LODR
Regulation 30 SAST-31.03.2022
REG 40(10) LODR-31.03.2022
